1. X
  2. LifeArc
Log inSign up
LifeArc
3,464 posts
LifeArc profile banner
user avatar

LifeArc

@lifearc1
Self-funded medical research organisation with one clear purpose – transforming the lives of people living with rare diseases and drug-resistant infections.
Stevenage, London, Edinburgh
lifearc.org
Joined February 2009
2,916
Following
7,515
Followers
RepliesRepliesMediaMedia
  • user avatar
    LifeArc
    @lifearc1
    19h
    We need your help to build a resource that reflects the full scope of work happening across rare diseases in the UK. If your organisation isn't on Raremap yet, request to be added now: raremap.co.uk/join/
  • user avatar
    LifeArc
    @lifearc1
    Aug 17
    Reasons to invest in rare disease research are not rare. Rare diseases are often described as too small, too complex or too expensive. But Alexion has proved that they can offer both the opportunity to change lives and generate financial returns. 🎥Watch the full video:
    00:00
  • user avatar
    LifeArc
    @lifearc1
    Aug 14
    Bio-Hermes-002 has now completed enrolment, with 28% of participants coming from traditionally understudied populations. We're proud to be part of the Bio-Hermes-002 study, which is testing whether a finger-prick blood test could help diagnose Alzheimer's disease.
  • user avatar
    LifeArc
    @lifearc1
    Aug 12
    #GAMRIC2026 is fast approaching! Valeria Gigante (WHO) tells us why this conference is so important for tackling drug-resistant infections, together. Register now: gamric.org #GlobalHealth #AMR
    00:00
  • user avatar
    LifeArc
    @lifearc1
    Aug 10
    What if patients with Hunter syndrome could become their own bone marrow donors? Professor Wynn shares how gene correction is transforming treatment, with dramatic results from clinical trials Watch this #LATSS2026 session and more on our YouTube channel: bit.ly/4wPKLgk
    00:00

Log in or sign up for X

See what’s happening and join the conversation

Continue with phone
or
Log in with username or email
Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.